comparemela.com

Latest Breaking News On - Brad brubaker - Page 2 : comparemela.com

Princeton Capital Management LLC Increases Stock Position in UiPath Inc (NYSE:PATH)

Princeton Capital Management LLC grew its position in UiPath Inc. (NYSE:PATH – Free Report) by 16.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 16,367 shares of the healthcare company’s stock after buying an additional 2,356 shares during the period. Princeton Capital Management LLC’s holdings in UiPath […]

UiPath Inc (NYSE:PATH) Shares Bought by Princeton Capital Management LLC

Princeton Capital Management LLC boosted its stake in UiPath Inc. (NYSE:PATH – Free Report) by 16.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 16,367 shares of the healthcare company’s stock after purchasing an additional 2,356 shares during the period. Princeton Capital Management LLC’s holdings in UiPath were worth $280,000 as of […]

Vanguard Personalized Indexing Management LLC Sells 1,844 Shares of UiPath Inc (NYSE:PATH)

Vanguard Personalized Indexing Management LLC lessened its stake in UiPath Inc. (NYSE:PATH – Free Report) by 4.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 44,496 shares of the healthcare company’s stock after selling 1,844 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in […]

Sowell Financial Services LLC Sells 9,102 Shares of UiPath Inc (NYSE:PATH)

Sowell Financial Services LLC trimmed its position in shares of UiPath Inc. (NYSE:PATH – Free Report) by 36.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,690 shares of the healthcare company’s stock after selling 9,102 shares during the period. Sowell […]

UiPath Inc (NYSE:PATH) Given Consensus Recommendation of Hold by Analysts

UiPath Inc. (NYSE:PATH – Get Free Report) has received a consensus rating of “Hold” from the fourteen analysts that are covering the company, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month target price among brokerages […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.